24.8.2021 19:47:09 CEST | Demant A/S |
Storaktionærmeddelelser
Selskabsmeddelelse nr. 2021-12
24. august 2021
Storaktionærmeddelelse vedrørende Canada Pension Plan Investment Board iht. værdipapirhandelslovens § 29
I henhold til værdipapirhandelslovens § 29 skal Demant hermed offentliggøre, at selskabet har modtaget følgende meddelelse:
Canada Pension Plan Investment Board har i en række transaktioner reduceret sin direkte og indirekte beholdning af stemmerettigheder og aktiekapital i Demant til under 5 % pr. 23. august 2021.
Yderligere information:
Koncernchef og adm. dir. Søren Nielsen
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Mathias Holten Møller, Head of Investor Relations
Christian Lange, IR Officer
Trine Kromann-Mikkelsen, VP Corporate Communication and Relations
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2021-12 Storaktionærmeddelelse.pdf
24.8.2021 19:47:09 CEST | Demant A/S |
Major shareholder announcements
Company announcement no 2021-12
24 August 2021
Major shareholder announcement concerning Canada Pension Plan Investment Board pursuant to section 29 of the Danish Securities Trading Act
Pursuant to section 29 of the Danish Securities Trading Act, Demant hereby makes public that the company has received the following announcement:
Canada Pension Plan Investment Board has in a number of transactions reduced its direct and indirect holding of voting rights and share capital in Demant to below 5% as at 23 August 2021.
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Mathias Holten Møller, Head of Investor Relations
Christian Lange, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communication and Relations
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2021-12 Major Shareholder Announcement.pdf
